Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11628162 Methods of treating cancer with an FGFR inhibitor

Patent 11628162 was granted and assigned to Incyte on April, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024517 Salts of an FGFR inhibitor
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors
0
Edits on 14 Aug, 2023
"Add patent inventor"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Krishnaswamy Yeleswaram0
Tao Ji0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 19 Apr, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 Apr, 2023
Edits made to:
Infobox (+33 properties)
Article (+179 characters)
‌

 US Patent 11628162 Methods of treating cancer with an FGFR inhibitor

Article

This application relates to methods of treating cancer in a patient in need thereof, comprising administering a Fibroblast Growth Factor Receptors (FGFR) inhibitor to the patient.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116281620
Date of Patent
April 18, 2023
0
Patent Application Number
168116400
Date Filed
March 6, 2020
0
Patent Citations
‌
US Patent 11173162 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 11174257 Salts of an FGFR inhibitor
0
‌
US Patent 10016348 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C
0
‌
US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
0
‌
US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10308644 Heterocyclic compounds as immunomodulators
0
‌
US Patent 10350240 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
0
‌
US Patent 10357431 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
0
‌
US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same
0
‌
US Patent 10632126 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10738048 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10813930 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 10851105 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10947230 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11014923 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 11053246 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 11407750 Derivatives of an FGFR inhibitor
0
‌
US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same
0
‌
US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same
0
Patent Primary Examiner
‌
Brian J Davis
0

Find more entities like US Patent 11628162 Methods of treating cancer with an FGFR inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo